“Key opinion leader” (KOL) is a term most often used to refer to a medical partner, expert, or external advisor whose voice is highly respected within their specific therapeutic field. KOLs have become vital to the drug development process, and many pharmaceutical companies are seeking deeper collaborations with KOLs.

Recent oncology conferences ASCO 2017 and EHA 2017 both offered special opportunities to attend satellite programs. These support the general congress objectives and invite communication, collaboration, and the chance to network with an international audience.